Doxazosin Tablet
Product Images NDC 50268-224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 50268-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (222 15)

1 (222 15)
This is a drug called Doxazosin, available only on prescription, that comes in a package of 50 tablets. Each tablet contains doxazosi mesylate equivalent to 1 mg doazosin. It should be stored at 20°C to 25°C, with excursions permitted from 15°C to 30°C, and away from children. The usual dosage can be found on the package insert. The text includes instructions for pharmacists to dispense with patient information.*
FDA Label Image

2 (223 15)

2 (223 15)
Doxazosin Tablets, USP is for prescription only. Each tablet contains Doxazosin Mesylate corresponding to 2mg Doxazosin. The tablets come in a pack with 50 unit dose tablets. The usual dosage should be read on the package insert that accompanies the tablets. It is advised to store the medication between 3-20°C or 25°C (68-70°F) as per the USP Controlled Room Temperature. The medication should be kept out of children's reach. The manufacturer information indicates that the medication is manufactured for Aukare, located in Pulaski, TN.*
FDA Label Image

4 (224 15)

4 (224 15)
Doxazosin Tablets are a prescription medication with each tablet of 4mg containing doxazosin mesylate. The package size is 50 tablets, which are individually packaged in 5x10 unit doses. The recommended storage temperature is between 20°C to 25°C, and the normal dosage instructions are mentioned in the package insert. The medication needs to be kept out of the reach of children. The document also provides the pharmacist with instructions to add patient information while dispensing the medication.*
FDA Label Image

8 (225 15)

8 (225 15)
This is a description of a medicine called Doxazosin Tablets, USP. It comes in a container of 50 tablets, and each tablet contains doxazosin mesylate equivalent to 8mg of doxazosin. The medicine should be stored at 20°C to 25°C, with excursions permitted from 15°C to 30°C. The medication should be kept out of reach of children. The usual dosage is listed in the package insert, and it should be dispensed with patient information by a pharmacist. The medicine is manufactured by AUKARE in Pulaski, TN.*
FDA Label Image

Doxazosin-structure.jpg (Doxazosin Structure)

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Table3.jpg (Table3)

Table3.jpg (Table3)
The text is a table showing summaries of effectiveness data in placebo-controlled trials for maximum flow, symptom score, and rate. The table includes mean baseline change, mean baseline change for placebo, and Doxazosin. It also includes the AUA questionnaire and the Modified Boyarsky Questionnaire scores for Studies 1 and 3, respectively. The text provides information on the duration of the titration and fixed dose efficacy phase of each study. The quality of the text is good.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.